Results 171 to 180 of about 123,173 (290)

WCN25-3639 GEORSPATIAL ANALYSIS OF CKD HOT SPOTS: INSIGHTS FROM 0.1 MILLION PARTICIPANTS SCREENING IN UDDANAM, INDIA

Kidney International Reports
Dilip Kumar K, Balaji Gummidi, Renu John, Kavita Yadav, Vivekanand Jha   +4 more
doaj   +1 more source

Chemerin as a Mediator of Hypertension and Cardiometabolic Diseases (A Comprehensive Review). [PDF]

Curr Hypertens Rep
McMillan R, Kirabo A.
europepmc   +1 more source

Role of Sleep Disturbances and Diabetes‐Related Distress on Glycemic Control: A Path Analysis

Research in Nursing &Health, EarlyView.
ABSTRACT Despite advancements in diabetes management technology, many patients with type 2 diabetes (T2D) struggle to achieve optimal glycemic control. Sleep disorders such as obstructive sleep apnea (OSA) and insomnia are common in T2D and linked to poor glycemic control. Insomnia, particularly with short sleep duration, may worsen glycemic control by
Bomin Jeon, Faith S. Luyster, Eileen R. Chasens   +2 more
wiley   +1 more source

Risks of cardiometabolic diseases in women with history of adverse pregnancy outcomes. [PDF]

J Hum Hypertens
Wang R, Chen YM, Wang L, Lei Q.
europepmc   +1 more source

GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?

The Laryngoscope, EarlyView.
Alina Zgardau, Ryan Chin Taw Cheong, Kenny Peter Pang, Brian W. Rotenberg   +3 more
wiley   +1 more source

Safety and Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists Use in Elderly People With Obesity—A Meta‐Analysis

Obesity, EarlyView.
ABSTRACT Objective This meta‐analysis evaluates the safety and efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) for the treatment of older adults with obesity compared to younger individuals. Methods A systematic review was conducted following PRISMA guidelines (PROSPERO CRD420251074381).
Inês Rego de Figueiredo, Filipa Sofia Simas, Angela Ghiletchi, João Oliveira Torres, José Silva‐Nunes   +4 more
wiley   +1 more source

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials

Obesity, EarlyView.
ABSTRACT Objective This study compared the efficacy of metabolic/bariatric surgery (MBS) and GLP‐1 receptor agonists (GLP‐1 RAs), including dual GLP‐1/GIP analogues, for weight and metabolic outcomes in adults with obesity. Methods A network meta‐analysis of randomized controlled trials compared MBS or GLP‐1 RAs versus lifestyle intervention in adults ...
Lucas Sabatella, Patricia M. Ortega, Víctor Valentí Azcárate, Fernando Rotellar Sastre, Adriana Uriz Pagola, Ahmed Ahmed, Sanjay Purkayastha, Carlota Tuero Ojanguren, Nuria Blanco Asensio, Manuel F. Landecho   +9 more
wiley   +1 more source

Associations of asthma with cardiometabolic diseases and multimorbidity: A cohort study in the UK Biobank. [PDF]

NPJ Prim Care Respir Med
Lin J, Cheng Y, Zhang Y, Kivimäki M, Carrillo-Larco RM, Xu C, Xu X.   +6 more
europepmc   +1 more source

Weekly Subcutaneous VK2735, a GIP/GLP‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study

Obesity, EarlyView.
Four doses of VK2735 and a placebo group were included in the VENTURE study. Adults who were overweight or had obesity had significant weight loss when taking any dose of VK2735 for 13 weeks. More people lost at least 10% of their body weight as the dose increased.
Harold E. Bays, Phillip Toth, Naim Alkhouri, John Pullman, Bradley Freilich, Joel Neutel, Summer Ji, Scott Stubbe, Parke Hedges, Brian Lian   +9 more
wiley   +1 more source

WCN25-3626 ASSESSMENT OF CAUSES OF DEATH IN A POPULATION-REPRESENTATIVE COHORT AT RISK OF CHRONIC KIDNEY DISEASE OF UNKNOWN ORIGIN, USING SmartVA TECHNOLOGY

Kidney International Reports
Balaji Gummidi, Rohina Joshi, Renu John, Dilip Kumar, Kavita Yadav, Vivekanand Jha   +5 more
doaj   +1 more source